Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free CRNX Stock Alerts

Crinetics Pharmaceuticals (CRNX) Earnings Date, Estimates & Call Transcripts

Crinetics Pharmaceuticals logo
$84.84 -0.01 (-0.01%)
As of 04:00 PM Eastern
Compare

Crinetics Pharmaceuticals Earnings Summary

Crinetics Pharmaceuticals released Q2 2026 earnings on August 3, 2026, reporting an EPS of -$1.14, which topped analysts' consensus estimates of -$1.18 by $0.04. Quarterly revenue rose 2336.9% year-over-year to $25.12 million, above the consensus estimate of $14.84 million. With a trailing EPS of -$5.04, Crinetics Pharmaceuticals' earnings are expected to grow next year, from ($4.83) to ($4.05) per share.

Upcoming Q3
Earnings Date
Nov. 5After Market ClosesEstimated
Consensus EPS
(Aug. 3)
-$1.18
Actual EPS
(Aug. 3)
-$1.14 Beat By $0.04
Actual Revenue
(Aug. 3)
$25.12M

Q2 2026 Earnings Resources

CRNX Upcoming Earnings

Crinetics Pharmaceuticals' next earnings date is estimated for Thursday, November 5, 2026, based on past reporting schedules.

Powered by Quartr
Get Crinetics Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Crinetics Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

CRNX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRNX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Crinetics Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$1.35-$1.33-$1.34
Q2 20262-$1.28-$1.22-$1.25
Q3 20262-$1.27-$1.18-$1.23
Q4 20262-$1.25-$1.10-$1.18

Crinetics Pharmaceuticals Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/5/2026
(Estimated)		--------
8/3/2026Q2 2026-$1.18-$1.14+$0.04-$1.14$14.84M$25.12M
5/7/2026Q1 2026-$1.22-$1.23 -$0.01-$1.23$8.51M$10.73M
2/26/2026Q4 2025-$1.37-$1.29+$0.08-$1.29$4.32M$6.16M
11/6/2025Q3 2025-$1.27-$1.38 -$0.11-$1.38$0.39M$0.14M
8/7/2025Q2 2025-$1.13-$1.23 -$0.10-$1.23$0.52M$1.03M
5/8/2025Q1 2025-$0.99-$1.04 -$0.05-$1.04$0.10M$0.36M
2/27/2025Q4 2024-$0.92-$0.88+$0.04-$0.88$0.73M-
11/12/2024Q3 2024-$0.91-$0.96 -$0.05-$0.96$0.22M-

Crinetics Pharmaceuticals Earnings - Frequently Asked Questions

Crinetics Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 5th, 2026 based off last year's report dates. Learn more on CRNX's earnings history.

In the previous quarter, Crinetics Pharmaceuticals (NASDAQ:CRNX) reported ($1.14) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.18) by $0.04. Learn more on analysts' earnings estimate vs. CRNX's actual earnings.

Crinetics Pharmaceuticals (NASDAQ:CRNX) has a recorded annual revenue of $7.70 million.

Crinetics Pharmaceuticals (NASDAQ:CRNX) has a recorded net income of -$465.32 million. CRNX has generated -$5.04 earnings per share over the last four quarters.

Crinetics Pharmaceuticals' earnings are expected to grow from ($4.83) per share to ($4.05) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:CRNX is sourced from Fiscal.ai, with the most recent quarter reported on 8/3/2026. New results are added as companies report their earnings.
From Our Partners
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
MILLIONAIRE MASTERCLASS INVITE: Altucher
James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altuche...
Paradigm Press | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
Buy These Stocks Before August 31st
Keith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwi...
TradeSmith | Sponsoredtc pixel
Bank of America grew this stake 139%
Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...
Behind the Markets | Sponsoredtc pixel
I found Rolls-Royce at $2 - now I see the same setup again
In 2022, Karim Rahemtulla recommended Rolls-Royce under $2 - a misunderstood aerospace name the market had wri...
Monument Traders Alliance | Sponsoredtc pixel
How a schoolteacher turned $100 into $355,000
In 1903, a Detroit schoolteacher put $100 into a struggling carmaker named Ford, just as cheap gasoline met th...
Stansberry Research | Sponsoredtc pixel
A $382 trillion migration and the position no one is talking about
Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...
Awesomely | Sponsoredtc pixel